Abstract
Objective
Most epidemiologic studies have shown serum triglycerides to be associated with colorectal adenoma. However, whether the association can be modified by smoking is unknown. We cross-sectionally investigated the association of serum triglycerides with the risk of adenoma by smoking status.
Methods
We identified 782 newly diagnosed adenoma cases from the examinees of a colorectal cancer screening program. All cases were diagnosed by a magnifying colonoscopy with dye spreading. We determined 738 controls without present illness or past history of adenoma from among the examinees. They provided their lifestyle information and fasting blood samples to measure their serum triglycerides. We calculated odds ratios (OR) and 95% confidence intervals (CI) of colorectal adenoma for serum triglycerides.
Results
High serum triglycerides were associated with colorectal adenoma (OR 1.5; 95% CI 1.1–2.0 for the highest versus the lowest quartile, P trend, 0.030). A stronger association was observed between three or more adenoma cases and study controls (OR 2.3; 95% CI 1.3–4.2, P trend, < 0.0010). After classifying the study subjects by smoking status, a significant linear risk trend was found in ever-smokers (P trend, 0.0018) but not in never-smokers (P trend, 0.94; P interaction, 0.067).
Conclusions
Our results suggested that a higher serum triglyceride level may be related to a larger number of adenomas. Adenoma development involving an elevated serum triglyceride level may be modified by smoking.
Similar content being viewed by others
References
World Health Organization, International Agency for Research on Cancer (2002) Chapter 5. Cancer-preventive effects; Weight and weight control; Colorectal cancer. In: IARC Handbooks of cancer prevention, vol 6. Weight control and physical activity. IARC Press, Lyon, pp 85–95
World Cancer Research Fund in association with American Institute for Cancer Research (1997) Chapter 4.10 Colon, rectum. In: Food, nutrition and the prevention of cancer: a global perspective. WCRF and AICR, Washington, DC, pp 216–251
NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease (1993) NIH Consensus Conference. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269:505–510
McKeown-Eyssen G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3:687–695
Kono S, Ikeda N, Yanai F, Yamamoto M, Shigematsu T (1990) Serum lipids and colorectal adenoma among male self-defence officials in northern Kyushu, Japan. Int J Epidemiol 19:274–278
Bird CL, Ingles SA, Frankl HD, Lee ER, Longnecker MP, Haile RW (1996) Serum lipids and adenomas of the left colon and rectum. Cancer Epidemiol Biomarkers Prev 5:607–612
Manus B, Adang RP, Ambergen AW, Brägelmann R, Armbrecht U, Stockbrügger RW (1997) The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prev 6:38–43
Park SK, Joo JS, Kim DH, Kim YE, Kang D, Yoo KY (2000) Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case–control study in Korea. J Korean Med Sci 15:690–695
Shinomiya S, Sasaki J, Kiyohara C, et al (2001) Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men. Cancer Lett 164:33–40
Misciagna G, De Michele G, Guerra V, Cisternino AM, Di Leo A, Freudenheim JL (2004) Serum fructosamine and colorectal adenomas. Eur J Epidemiol 19:425–432
Muto T, Bussey HJ, Morson BC (1975) The evolution of cancer of the colon and rectum. Cancer 36:2251–2270
Niho N, Takahashi M, Kitamura T, et al (2003) Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res 63:6090–6095
Niho N, Mutoh M, Takahashi M, Tsutsumi K, Sugimura T, Wakabayashi K (2005) Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc Natl Acad Sci USA 102:2970–2974
Brown JR, DuBois RN (2005) COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 23:2840–2855
Raju J, Bird RP (2003) Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res 63:6595–6601
Ochiai M, Ogawa K, Wakabayashi K, et al (1991) Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Nagase analbuminemic rats. Jpn J Cancer Res 82:363–366
Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR (1997) Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer 29:69–76
International Agency for Research on Cancer (eds) (2004) IARC monographs on the evaluation of the carcinogenic risk to humans, vol 83. Tobacco smoking and involuntary smoking. IARC, Lyon
Sano Y, Saito Y, Fu KI, et al (2005) Efficacy of magnifying chromoendoscopy for the differential diagnosis of colorectal lesions. Digest Endosc 17:105–116
Fu KI, Sano Y, Kato S, et al (2004) Chromoendoscopy using indigo carmine dye spraying with magnifying observation is the most reliable method for differential diagnosis between non-neoplastic and neoplastic colorectal lesions: a prospective study. Endoscopy 36:1089–1093
Huang Q, Fukami N, Kashida H, et al (2004) Interobserver and intra-observer consistency in the endoscopic assessment of colonic pit patterns. Gastrointest Endosc 60:520–526
Science and Technology Agency (eds) (2000) Standard tables of food composition in Japan. The fifth revised edition (in Japanese). Printing Bureau, Ministry of Finance, Tokyo
Tsubono Y, Takamori S, Kobayashi M, et al (1996) A data-based approach for designing a semiquantitative food frequency questionnaire for a population-based prospective study in Japan. J Epidemiol 6:45–53
Tsugane S, Kobayashi M, Sasaki S (2003) Validity of the self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I: comparison with dietary records for main nutrients. J Epidemiol 13:S51–S56
Mantel N (1963) Chi-square tests with one degree of freedom; extensions of the Mantel–Haenszel Procedure. J Am Stat Assoc 58:690–700
Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27
Togashi K, Konishi F, Ishizuka T, Sato T, Senba S, Kanazawa K (1999) Efficacy of magnifying endoscopy in the differential diagnosis of neoplastic and non-neoplastic polyps of the large bowel. Dis Colon Rectum 42:1602–1608
No Author listed (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 58:S3–S43
Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162–168
Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343:169–174
Schoen RE, Tangen CM, Kuller LH, et al (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147–1154
Tsushima M, Nomura AM, Lee J, Stemmermann GN (2005) Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 50:499–505
Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10:937–941
Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6:164–179
Sandhu MS, Dunger DB, Giovannucci EL (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94:972–980
Winawer S, Fletcher R, Rex D, et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 124:544–560
Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA (1998) Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 9:455–462
Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH (1999) Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Tele-mark Polyp Study I. Scand J Gastroenterol 34:414–420
Tabuchi M, Kitayama J, Nagawa H (2006) Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol 12:1261–1264
Soetikno R, Friedland S, Kaltenbach T, Chayama K, Tanaka S (2006) Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology 130:566–576 quiz 588-9
Acknowledgments
We thank Dr. Yasushi Sano, Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, for his helpful comments. This study was supported by a Grant-in-Aid for Cancer Research and for the Third-Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the program for promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency (PMDA).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Otani, T., Iwasaki, M., Ikeda, S. et al. Serum triglycerides and colorectal adenoma in a case–control study among cancer screening examinees (Japan). Cancer Causes Control 17, 1245–1252 (2006). https://doi.org/10.1007/s10552-006-0065-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-006-0065-z